← Browse by Condition
Medical Condition
mixed phenotype acute leukemia
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 2, Phase 1, Phase 2
NCT04195633 Phase 2
Recruiting
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
Enrollment
60 pts
Location
United States
Sponsor
Fred Hutchinson Cancer Center
NCT07356154 Phase 1, Phase 2
Recruiting
A Study of Revumenib and Mezigdomide in People With Leukemia
Enrollment
52 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
NCT06928662 Phase 1, Phase 2
Recruiting
Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse
Enrollment
36 pts
Location
United States
Sponsor
Fred Hutchinson Cancer Center
NCT03779854 Phase 2
Recruiting
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
Enrollment
68 pts
Location
United States
Sponsor
Fred Hutchinson Cancer Center